Because research will beat blood cancer
Donate nowBlood Cancer UK
We research, we support, we care. Because it’s time to beat leukaemia, lymphoma, myeloma and all types of blood cancer.
How can we help?
Get involved
Latest news and stories
Latest evidence on COVID-19 vaccines and blood cancer
Our Healthcare Professional Advisory Panel has released this statement to help you understand the latest evidence on COVID-19 vaccines and blood cancer.
UK’s first bispecific drug for myeloma approved
The new drug, elranatamab, has been approved by the National Institute for Health and Care Excellence.
We're funding £1.3 worth of new myeloma research
The funding includes a grant for a team who are developing a new blood test to help diagnose myeloma.
Keep in touch with us
Get the latest news from Blood Cancer UK directly to your inbox.
We will keep you updated about our work and the ways you can help, including campaigns and events. We promise to respect your privacy and we will never sell or swap your details.